arrow_back Back to App

Advancing Chronic Pain Research: Better Data and Public Information

This act aims to improve the understanding and treatment of chronic pain, affecting many citizens. It will lead to better data on the causes and effects of pain, and a public website with information and tools for patients and researchers. Citizens will gain access to reliable information, which can help them better manage their health conditions.
Key points
A system will be established to collect data on chronic pain to better understand its incidence and impact on people's lives.
A public website, the "Chronic Pain Information Hub," will be launched, featuring research summaries, clinical tools, and resources for patients.
Collaborating experts and organizations will be required to disclose any financial ties to drug manufacturers, increasing research transparency.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7164
Sponsor: Rep. Caraveo, Yadira [D-CO-8]
Process start date: 2024-01-31
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Advancing Research for Chronic Pain Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7164.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-01-31.

What are the main provisions?

Key points include:

  • A system will be established to collect data on chronic pain to better understand its incidence and impact on people's lives.
  • A public website, the "Chronic Pain Information Hub," will be launched, featuring research summaries, clinical tools, and resources for patients.
  • Collaborating experts and organizations will be required to disclose any financial ties to drug manufacturers, increasing research transparency.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Caraveo, Yadira [D-CO-8].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health